Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Ophthalmol Case Rep ; 34: 102024, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38426069

ABSTRACT

Purpose: To study the emerging trend of development of secondary acquired nasolacrimal duct obstruction (SALDO) in the cases treated for rhino-orbito-cerebral mucormycosis (ROCM). Observations: Prospective, interventional case series of five patients who developed SALDO post-surgical and medical management of ROCM. The mean age was 45.4 years (range: 40-62 years), all five being males. Right lacrimal drainage pathways was involved slightly more than the left (right:left = 3:2). Epiphora and discharge were the main presenting features. All five patients were treated with extensive debridement of the nose, sinuses, orbit and cerebral involvement as needed followed by medical management for ROCM. CT- Dacryocystography for all 5 patients showed obstruction at the lower end of the nasolacrimal duct. The patients underwent external dacryocystorhinostomy with mitomycin-C with or without intubation with good anatomical and functional outcomes at 6 months follow-up. Conclusions and importance: The present series highlights the possible etiology of development of SALDO in cases treated for ROCM, its management and discusses the role of Computed Tomography Dacryocystography (CT-DCG) in understanding the pathophysiology of the development of SALDO along with delineating the spatial relationship of the lacrimal drainage system with the surrounding structures.

2.
Cureus ; 14(6): e25703, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35812580

ABSTRACT

Background and objective Dry eye disease (DED) is one of the most common reasons why patients seek eye care. With increasing age, widespread adoption of technology, and environmental changes, its prevalence has been on the rise, and will likely increase further. Meibomian gland dysfunction (MGD) is the most common cause of DED; however, for a variety of reasons, it is currently underrecognized. We aimed to determine the etiology of DED from a sample of patients visiting our center with dry eye symptoms and study the characteristics of those diagnosed with MGD. Methodology We conducted this prospective observational study from 2016 to 2018. We included patients with two or more dry eye symptoms and excluded those with systemic conditions or structural issues causing dry eye. Each patient underwent a detailed evaluation of the dry eye, including the Ocular Surface Disease Index (OSDI) questionnaire, Oxford corneal staining, Schirmer test 1, tear film break-up time (TBUT), tear meniscus height, and non-contact meibography. All patients subsequently received appropriate treatment. Patients with MGD were evaluated once again after one month. Results We included 250 patients in the study. Their mean (standard deviation) age was 45.3 (16.9) years, and 138 (55%) of them were males. Grittiness and itching were the most common symptoms. MGD was the most common diagnosis, seen in 100 (40%), followed by chronic allergic conjunctivitis. Patients with MGD were more likely to be elderly and had significantly worse DED parameters. Over half of all MGD cases were mild or less severe. With appropriate treatment, all DED metrics improved significantly. Conclusions MGD was the most common cause of DED in our sample. Patients with MGD were more likely to be elderly and had more severe DED, consistent with other studies in the literature. With specific treatment of MGD, there was a significant improvement in the patients' condition. DED is a growing ocular health issue that causes great detriment to patients' quality of life and finances. Our findings support the need for a detailed evaluation and specific treatment of patients presenting with dry eye symptoms.

3.
Cureus ; 14(2): e21805, 2022 Feb.
Article in English | MEDLINE | ID: mdl-35251869

ABSTRACT

INTRODUCTION: Headache is a common cause of disability worldwide and can disrupt the education and social life of children. Children regularly present to ophthalmologists with headache. So, we aimed to describe the characteristics of headache in children presenting to the ophthalmology outpatient department (OPD) in our center. METHODOLOGY: We conducted this cross-sectional, prospective study in Bangalore, India. We included all children aged 5-18 years, presenting with headache to the ophthalmology OPD, from September 2018 to September 2020, and excluded nonverbal children, those with prior head trauma, diagnosed psychiatric illnesses, or epilepsy. We provided each child with a headache questionnaire, following which they received a detailed ophthalmologic evaluation. We performed relevant descriptive and inferential analyses. RESULTS: We included 311 children, with a mean age of 11.1 years. Sixty-eight percent were males. Fifty-one percent reported holocranial headache, and 28% reported frontal headache. Sixty-nine percent reported screen time of ≥2 hours/day. The most common refractive error (RE) was myopia, seen in 48%. The most common type of headache was headache associated with refractive errors (HARE), seen in 64%, followed by migraine, in 19%. Children with HARE were more likely to be males, have daily screen time of >2 hours/day, or have myopia. Their headache was more likely to be for >1 month, or have frontal localization. Children with headache due to other causes were more likely to be adolescents. DISCUSSION: We found that almost two-thirds of children presenting to our ophthalmology OPD had HARE. Our findings support the association of REs with headache. Children with HARE had a longer history and predominantly frontal localization. Further, they reported longer screen time, a significant finding in today's world. Ophthalmologists must be aware of the various etiologies of headache and ensure that each child with headache receives a full ophthalmologic evaluation.

4.
Int Ophthalmol ; 41(6): 2033-2039, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33611762

ABSTRACT

PURPOSE: To analyze the risk factors and estimate the risk period for tumor recurrence in intraocular retinoblastoma (RB). METHODS: Retrospective study of 60 RB patients. RESULTS: The mean age at presentation with RB was 16 months (median 11 months; range 1-84 months). Tumor was unilateral in 13 (22%) and bilateral in 47 (78%) patients. Of 83 eyes with intraocular RB, group B (n = 27; 33%) tumors were more common based on International Classification of Intraocular Retinoblastoma. All cases received intravenous chemotherapy as a primary treatment. Over a mean follow-up period of 57 months (median 38 months; range 12-185 months) post-primary treatment, 44 (73%) patients developed tumor recurrence. The mean interval between the completion of primary treatment and first tumor recurrence was 5 months (median 3 months; range 1-24 months). The total duration of treatment for complete tumor control including treatment of tumor recurrences was 20 months (median 19 months; 2-58 months). By multivariate analysis, the factors predictive of tumor recurrence were multiple tumors (p = 0.008) and retinal detachment (p = 0.003) at presentation. Kaplan-Meier estimate of tumor recurrence at 6 months, 1 year, 3 years, and 5 years was 20%, 31%, 68%, and 73%, respectively. There was no tumor recurrence beyond 5 years since primary treatment. CONCLUSION: Multiple tumors and retinal detachment at presentation are risk factors for tumor recurrence in RB. Close follow-up is mandatory for at least 5 years since the initiation of treatment for RB.


Subject(s)
Retinal Neoplasms , Retinoblastoma , Child , Child, Preschool , Humans , Infant , Neoplasm Recurrence, Local/epidemiology , Retinal Neoplasms/diagnosis , Retinal Neoplasms/drug therapy , Retinal Neoplasms/epidemiology , Retinoblastoma/drug therapy , Retinoblastoma/epidemiology , Retrospective Studies , Risk Factors
5.
Oman J Ophthalmol ; 4(1): 21-4, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21713236

ABSTRACT

BACKGROUND: High-dose systemic steroids are the primary modality of treatment for idiopathic orbital inflammatory syndrome (IOIS). Occasionally patients experience a relapse of symptoms on tapering steroids or require large doses of steroid, predisposing them to the adverse effects of steroids. AIM: We present our experience with the management of three patients with recalcitrant IOIS, with immunosuppressive therapy, using antimetabolites. MATERIALS AND METHODS: A retrospective review of the medical records of the patients being reported. RESULTS: Two patients were treated with Methotrexate and one with Azathioprine for a duration of 6-24 months. Two patients were symptom-free three years after stopping the medication. One was doing well clinically with methotrexate therapy alone, when he was lost to follow-up after six months. No adverse effects of immunosuppressive therapy were encountered. CONCLUSION: High-dose systemic steroid therapy is the first-line treatment for IOIS, but in refractory or steroid-dependent cases, immunosuppressive therapy with antimetabolites is a safe and effective treatment alternative to steroids. However, treatment with antimetabolites warrants close monitoring for complications like bone marrow suppression and liver dysfunction, especially because long-term treatment is required.

6.
J Assoc Physicians India ; 58: 24-8, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20649095

ABSTRACT

AIM: To describe the diverse clinical and laboratory manifestations of scrub typhus diagnosed in Pondicherry Institute of Medical Sciences, Pondicherry. MATERIALS AND METHODS: All cases of febrile illness diagnosed as scrub typhus over a period of 2 years were analysed. Diagnosis was based on the presence of the eschar and/or positive Weil Felix test with a titre of > 1:80. RESULTS: Fifty cases of scrub typhus were seen over a period of 2 years (April 2006 and April 2008). Common symptoms were high grade fever of 7-14 days duration, nausea, vomiting, headache, myalgia, cough and breathlessness. Eschar was seen in 23 cases (46%) and the common sites were axilla, breast and groin. Weil Felix test was positive in 39 cases (78%). Liver enzymes were elevated in nearly all cases (95.9%). Multiple Organ Dysfunction Syndrome (MODS) was present in one third of our patients (17 out of 50, 34%). Hypotension (8 patients, 16%), renal impairment (6 patients, 12%), ARDS (4 patients, 8%) and meningitis (7 patients, 14%) were some of the important complications. There was a dramatic response to doxycycline in nearly all the patients. CONCLUSION: Scrub typhus has emerged as an important cause of febrile illness in Pondicherry. Empirical treatment with doxycycline is justified in endemic areas.


Subject(s)
Disease Outbreaks , Orientia tsutsugamushi/immunology , Scrub Typhus/diagnosis , Adolescent , Adult , Aged , Aged, 80 and over , Agglutination Tests , Anti-Bacterial Agents/therapeutic use , Doxycycline/therapeutic use , Female , Humans , Immunoglobulin M , India/epidemiology , Male , Middle Aged , Multiple Organ Failure/complications , Scrub Typhus/complications , Scrub Typhus/drug therapy , Scrub Typhus/epidemiology , Severity of Illness Index , Treatment Outcome , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...